Tirzepatide is a dual agonist acting on GLP-1 and GIP receptors
5,6,7 GLP-1 is a peptide produced by the cleavage of proglucagon, mainly synthesized in the intestinal mucosal L-cells, pancreatic islet -cells, and neurons in the nucleus of the solitary tract
The average peak time of subcutaneous injection is 48 hours
Reliable wholesale distribution support
In addition, GLP-1R can be continuously activated to activate cAMP and P38 (94) and inhibit the conduction of the AKT and ERK1/2 signaling pathways ( in vivo and inducing the apoptosis of human pancreatic cancer cells in vitro ( 95)
Skincare brands are now jumping on the trend not by using GLP-1 actives, but by repackaging familiar anti-aging ingredients for GLP-1 patients experiencing sagging, volume loss, and wrinkles